Neurofibromatosis Type 1 (NF1) and Scoliosis: Café-au-Lait Spots, Spinal Deformity & Expert Care in Shanghai

Understanding Neurofibromatosis Type 1 (NF1)

Neurofibromatosis Type 1 (NF1, 神经纤维瘤病I型) — also known as von Recklinghausen disease — is one of the most common single-gene disorders in humans, affecting approximately 1 in 3,000 people worldwide regardless of ethnicity or sex. It is caused by a mutation in the NF1 gene on chromosome 17q11.2, which encodes neurofibromin, a tumor suppressor protein that regulates cell growth through the RAS signaling pathway.

NF1 is an autosomal dominant condition: a single mutated copy of the gene is sufficient to cause disease. Approximately 50% of cases arise from de novo (new) mutations with no family history. The condition is characterized by extraordinary clinical variability — even within the same family, manifestations can range from mild skin findings to severe neurological, skeletal, and oncological complications.

The Classic Diagnostic Features of NF1

Diagnosis of NF1 is clinical, based on the NIH Diagnostic Criteria (1987, updated 2021). A diagnosis requires two or more of the following features:

1. Café-au-Lait Spots (咋啡色斑 / 牛奶咋啡色斑)

• Flat, evenly pigmented brown skin macules resembling the color of coffee with milk
• Diagnostic threshold: ≥6 spots, each ≥5 mm in prepubertal children or ≥15 mm in post-pubertal individuals
• Present in over 99% of NF1 patients; often the earliest and most consistent sign
• Typically appear in the first year of life and increase in number and size through childhood
• Location: anywhere on the body, but classically spare the face, palms, and soles
• Axillary or inguinal freckling (Crowe's sign) is a highly specific NF1 feature

2. Neurofibromas (神经纤维瘤)

Neurofibromas are benign peripheral nerve sheath tumors arising from Schwann cells, fibroblasts, and mast cells within the nerve. There are three main types:

• Cutaneous neurofibromas: Soft, flesh-colored skin nodules; appear in late childhood/adolescence; increase in number with age; not associated with malignant transformation
• Subcutaneous neurofibromas: Firm, deeper nodules along peripheral nerves; may be tender; also benign
• Plexiform neurofibromas: Diffuse, infiltrating tumors involving multiple nerve fascicles; present from birth; may cause disfigurement, pain, and functional impairment; 10–15% risk of malignant transformation to malignant peripheral nerve sheath tumor (MPNST)

3. Lisch Nodules

• Melanocytic hamartomas of the iris; appear as small, dome-shaped, tan-to-brown nodules on slit-lamp examination
• Present in >90% of adults with NF1; rare in other conditions — highly specific for NF1
• Asymptomatic and do not affect vision

4. Optic Pathway Gliomas (OPG)

• Low-grade gliomas (pilocytic astrocytoma) of the optic nerve, chiasm, or optic tract
• Occur in 15–20% of NF1 patients; symptomatic in approximately one-third of those affected
• Symptoms: visual loss, proptosis, precocious puberty (if hypothalamic involvement)
• Require regular ophthalmological surveillance in childhood

5. Distinctive Osseous Lesions

• Sphenoid wing dysplasia, long bone cortical thinning, pseudarthrosis of the tibia
• Scoliosis (see below)

6. First-Degree Relative with NF1

• A parent, sibling, or child meeting NF1 diagnostic criteria

7. Germline NF1 Pathogenic Variant

• Identified on molecular genetic testing (added in 2021 updated criteria)

NF1-Associated Scoliosis: A Distinct and Challenging Problem

Scoliosis (脊柱侧弯) occurs in approximately 10–26% of NF1 patients — a rate significantly higher than the general population (2–3%). NF1-associated scoliosis is not a single entity but encompasses two distinct types with very different natural histories and treatment implications.

Type 1: Non-Dystrophic Scoliosis

• Resembles idiopathic adolescent scoliosis in appearance and behavior
• Long, sweeping curves involving many vertebral levels
• Generally responds well to standard scoliosis management (bracing, conventional surgery)
• May convert to dystrophic type over time — requires vigilant monitoring

Type 2: Dystrophic Scoliosis (NF1-Specific)

Dystrophic scoliosis is the hallmark spinal manifestation of NF1 and is unique to this condition. It is characterized by:

• Short, sharply angulated curves (typically 4–6 vertebral segments) with severe rotation
• Vertebral scalloping: Posterior erosion of vertebral bodies from dural ectasia or adjacent neurofibromas
• Rib penciling: Thinning and tapering of ribs at the curve apex
• Vertebral wedging and rotation: Severe structural deformity of individual vertebrae
• Foraminal enlargement: Widening of neural foramina from intraspinal neurofibromas or dural ectasia
• Intraspinal neurofibromas: Tumors within the spinal canal that may cause cord compression
• Rapid progression: Dystrophic curves progress faster and more unpredictably than idiopathic scoliosis
• High pseudarthrosis rate: Fusion failure after surgery is significantly more common than in idiopathic scoliosis

Why NF1 Scoliosis Is Different from Idiopathic Scoliosis

Clinical Presentation and Surveillance

NF1-associated scoliosis may be asymptomatic in early stages, detected only on routine screening. Warning signs requiring urgent evaluation include:

• Visible spinal asymmetry, shoulder or hip unevenness, or rib hump
• Back pain (unusual in idiopathic scoliosis; more common in NF1)
• Neurological symptoms: leg weakness, numbness, bladder or bowel dysfunction — suggesting cord compression from intraspinal neurofibroma
• Rapid curve progression on serial X-rays

All NF1 patients should undergo annual spinal assessment from childhood through skeletal maturity, with full-length standing spine X-rays when scoliosis is detected.

Diagnosis and Imaging

• Full-length standing posteroanterior and lateral spine X-rays: Cobb angle measurement; assessment for dystrophic features (scalloping, wedging, rib penciling)
• MRI of the entire spine: Essential in NF1 scoliosis to identify intraspinal neurofibromas, dural ectasia, and cord compression before any surgical planning
• CT spine: Detailed bony anatomy for surgical planning; pedicle morphology assessment
• Genetic testing: NF1 gene sequencing and deletion/duplication analysis; confirms diagnosis and identifies high-risk genotypes (whole-gene deletion associated with more severe phenotype)

Treatment

Observation

• For small curves (<20°) without dystrophic features: close monitoring with 6-monthly X-rays
• Any evidence of dystrophic features warrants more aggressive surveillance regardless of curve magnitude

Bracing

• May slow progression in non-dystrophic NF1 scoliosis
• Generally ineffective for dystrophic curves due to the underlying bony dysplasia and rapid progression
• Not a substitute for surgical planning in dystrophic cases

Surgical Treatment

Surgery is the definitive treatment for progressive or severe NF1 scoliosis. Key principles differ significantly from idiopathic scoliosis surgery:

• Early surgical intervention: Dystrophic curves should be treated earlier than idiopathic curves — waiting for larger curves increases surgical complexity and complication risk
• Combined anterior-posterior fusion: Often required for dystrophic curves to achieve adequate correction and reduce pseudarthrosis risk; posterior-only fusion has higher failure rates in NF1
• Intraspinal neurofibroma resection: Must be addressed before or during spinal fusion if cord compression is present; requires neurosurgical collaboration
• Instrumentation strategy: Pedicle screw fixation preferred; pedicle morphology may be abnormal in NF1, requiring CT-guided planning or navigation
• Bone grafting: Autologous iliac crest bone graft is preferred to reduce pseudarthrosis risk; BMP (bone morphogenetic protein) may be used adjunctively
• Intraoperative neuromonitoring: MEPs and SSEPs mandatory given the risk of intraspinal pathology

Selumetinib (MEK Inhibitor) for Plexiform Neurofibromas

For NF1 patients with symptomatic, inoperable plexiform neurofibromas, selumetinib (a MEK inhibitor targeting the RAS-MAPK pathway) is now approved and has demonstrated significant tumor shrinkage in clinical trials. While not a treatment for scoliosis itself, it may reduce the burden of paraspinal neurofibromas contributing to spinal deformity.

Multidisciplinary Care: The NF1 Team

NF1 is a systemic condition requiring lifelong multidisciplinary surveillance. A comprehensive NF1 care team includes:

• Clinical geneticist / genetic counselor: Diagnosis, family counseling, molecular testing
• Dermatologist: Monitoring of café-au-lait spots and cutaneous neurofibromas
• Orthopedic spine surgeon: Scoliosis surveillance and surgical management
• Neurosurgeon: Intraspinal neurofibroma resection, optic pathway glioma management
• Ophthalmologist: Annual visual acuity and optic nerve assessment
• Neurologist / neuro-oncologist: MPNST surveillance, OPG treatment
• Pediatrician / internist: Hypertension monitoring (renal artery stenosis, pheochromocytoma)
• Psychologist / educational specialist: Learning disabilities affect 30–65% of NF1 patients

Where to Seek Specialist Care in Shanghai

Zhongshan Hospital (中山医院), Fudan University — Orthopedics & Spine Surgery

Zhongshan Hospital's orthopedic department offers advanced spine surgery capabilities for complex deformity cases including NF1-associated scoliosis:

• Dr. Chen Shuang (陈双) — Orthopedics & Spine Surgery at Zhongshan Hospital; experienced in complex spinal deformity and reconstruction

Longhua Hospital (龙华医院) — Spinal Disease

Longhua Hospital offers integrative management of spinal conditions, combining TCM-based rehabilitation with conventional orthopedic care:

• Spinal Disease at Longhua Hospital Shanghai — Comprehensive spinal care including conservative management and post-surgical rehabilitation

Ruijin Hospital (瑞金医院) — Dermatology

For the dermatological manifestations of NF1 — including monitoring of café-au-lait spots, cutaneous neurofibromas, and skin surveillance for malignant transformation:

• Dr. Zheng Jie (郑捷) — Director of Dermatology at Ruijin Hospital; expert in complex inflammatory and neoplastic skin conditions

How CMCS Can Help

NF1 is a lifelong condition that requires coordinated care across multiple specialties. For international patients and families navigating NF1 management in Shanghai, CMCS provides:

• Coordination of multidisciplinary NF1 evaluation across dermatology, orthopedics, neurology, and genetics
• Priority appointments with spine surgeons for scoliosis assessment and surgical planning
• Pre-consultation review of spine X-rays, MRI, and genetic reports
• Medical interpretation during all specialist consultations and surgical discussions
• Coordination of genetic counseling and molecular testing
• Long-term surveillance planning and follow-up coordination

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com